Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 5/20 | 0.64 |
| ▸ | MAOB | P27338 | 5/20 | 0.61 |
| ▸ | PPARG | P37231 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 3/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16592154 | 0.86 | MAOB (0.60) | HTR2CMAOBPPARGSMN1; SMN2MAPT | |
| SCHEMBL15583974 | 0.85 | MAOB (0.61) | HTR2CMAOBPPARGMAOAFFAR1 | |
| SCHEMBL16589279 | 0.84 | MAOB (0.49) | HTR2CMAOBPPARGSMN1; SMN2GAA | |
| SCHEMBL15583971 | 0.81 | HTR2C (0.53) | HTR2CMAOBPPARGSMN1; SMN2MAOA | |
| SCHEMBL16592148 | 0.81 | HTR2C (0.67) | HTR2CMAOBPPARGMAOAFFAR1 | |
| SCHEMBL16592147 | 0.81 | PPARG (0.47) | HTR2CMAOBPPARGMAOAFFAR1 | |
| SCHEMBL16592127 | 0.80 | PPARG (0.46) | HTR2CMAOBPPARGMAOA | |
| SCHEMBL22623196 | 0.76 | MAOB (0.53) | HTR2CMAOBPPARGSMN1; SMN2GAA | |
| SCHEMBL16592150 | 0.76 | MAOA (0.44) | HTR2CMAOBPPARGMAOANPC1 | |
| SCHEMBL16592134 | 0.74 | HTR2C (0.48) | HTR2CMAPTNPC1RAB9ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9434695-B2 | Nitrogenous heterocyclic derivatives and their application in drugs | SUNSHINE LAKE PHARMA CO., LTD (CN) | 2016-09-06 | — | — | US | disclosed |
| US-20150087639-A1 | Nitrogenous Heterocyclic Derivatives And Their Application In Drugs | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2015-03-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150087639-A1 | Nitrogenous Heterocyclic Derivatives And Their Application In Drugs | TNNC1, TNNI3, IAPP | HTR2C 4209/4885MAOB 383/4885PPARG 2214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.